MannKind Corp
MNKD
#5812
Rank
โ‚น117.70 B
Marketcap
โ‚น365.95
Share price
3.72%
Change (1 day)
-23.82%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2023 (TTM): -โ‚น15.60

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -โ‚น12.20. In 2022 the company made an earnings per share (EPS) of -โ‚น31.90 a decrease over its 2021 EPS that were of -โ‚น30.03.

EPS history for MannKind Corp from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น15.60-51.09%
2022-โ‚น31.906.25%
2021-โ‚น30.0328%
2020-โ‚น23.46-7.41%
2019-โ‚น25.33-55.74%
2018-โ‚น57.24-45.05%
2017-โ‚น104.15-188.1%
2016โ‚น118.23-128.31%
2015-โ‚น417.5574.51%
2014-โ‚น239.27-20.31%
2013-โ‚น300.26-32.63%
2012-โ‚น445.70-28.03%
2011-โ‚น619.29-12%
2010-โ‚น703.74-27.54%
2009-โ‚น971.17-30.3%
2008-โ‚น1,393-18.85%
2007-โ‚น1,717-19.03%
2006-โ‚น2,12156.94%
2005-โ‚น1,351-21.74%
2004-โ‚น1,727

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น71.31-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น382.61-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚น2,896-23,843.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น93.15-863.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น330.29-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น277.74 2,176.92%๐Ÿ‡บ๐Ÿ‡ธ USA